Loading...
Repurposing Drugs in Oncology (ReDO)—Propranolol as an anti-cancer agent
Propranolol (PRO) is a well-known and widely used non-selective beta-adrenergic receptor antagonist (beta-blocker), with a range of actions which are of interest in an oncological context. PRO displays effects on cellular proliferation and invasion, on the immune system, on the angiogenic cascade, a...
Saved in:
| Published in: | Ecancermedicalscience |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Cancer Intelligence
2016
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5102691/ https://ncbi.nlm.nih.gov/pubmed/27899953 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2016.680 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|